Portfolio

ABOUT: A biotechnology company that addresses novel genome engineering of various organisms such as plants, microbes and animals. 

FUNDING:  Completed the series seed financial round with $7.85 million in July 2022.

INVESTMENT: A $100,000 UMDF research grant has been converted to equity.

FINANCING STATUS: Venture Capital-Backed

WEBSITE: napigen.com

The MITO Fund logo

Interested in having
The Mito Fund
explore investment
in your company?

Click here to start a
conversation with us.

More Portfolio Announcements
Coming Soon

MitoFund-Candle

Looking to support UMDF through Venture Philanthropy?